rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2000-8-22
|
pubmed:abstractText |
To compare the antiviral activity of abacavir (ABC) with stable background therapy (SBG) and SBG alone in antiretroviral therapy-experienced subjects as demonstrated by the proportion of subjects with plasma HIV-1 RNA < or = 400 copies/ml, plasma HIV-1 RNA and CD4 cell count profiles, and safety and tolerance of the two regimens over 16 weeks.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-9370
|
pubmed:author |
pubmed-author:Ait-KhaledMM,
pubmed-author:ArastehKK,
pubmed-author:BernasconiEE,
pubmed-author:ClotetBB,
pubmed-author:CutrellAA,
pubmed-author:JeantilsVV,
pubmed-author:JostJJ,
pubmed-author:KatlamaCC,
pubmed-author:PlettenbergAA,
pubmed-author:PurdomPP,
pubmed-author:StoneCC
|
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
781-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10839585-Adolescent,
pubmed-meshheading:10839585-Adult,
pubmed-meshheading:10839585-Anti-HIV Agents,
pubmed-meshheading:10839585-CD4 Lymphocyte Count,
pubmed-meshheading:10839585-Dideoxynucleosides,
pubmed-meshheading:10839585-Double-Blind Method,
pubmed-meshheading:10839585-Drug Resistance, Microbial,
pubmed-meshheading:10839585-Drug Therapy, Combination,
pubmed-meshheading:10839585-Female,
pubmed-meshheading:10839585-Genotype,
pubmed-meshheading:10839585-HIV Infections,
pubmed-meshheading:10839585-HIV Reverse Transcriptase,
pubmed-meshheading:10839585-HIV-1,
pubmed-meshheading:10839585-Humans,
pubmed-meshheading:10839585-Male,
pubmed-meshheading:10839585-Middle Aged,
pubmed-meshheading:10839585-Phenotype,
pubmed-meshheading:10839585-RNA, Viral,
pubmed-meshheading:10839585-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10839585-Treatment Outcome,
pubmed-meshheading:10839585-Viral Load
|
pubmed:year |
2000
|
pubmed:articleTitle |
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study Team.
|
pubmed:affiliation |
Hopital de la Pitie Salpetriere, Paris, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|